Data / Form D filings / Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc.: Form D filing
Dova Pharmaceuticals, Inc., a pharmaceuticals company in Charlottesville, VA, filed a Form D with the SEC in 2016. The latest, on September 23, 2016, reports $10 million sold of a $40 million offering to 1 investor.
Find out what Dova Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 GARRETT STREET, SUITE S, Charlottesville, VA, 22902
- Phone
- (434) 980-8105
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1685071
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2016 | New notice | $40,000,000 | $10,000,000 | $30,000,000 | 1 | Sep 19, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Russell T. Schundler | Executive Officer, Promoter | |
| PBM Capital Investments T. LLC | Promoter | |
| James C. Reebals | Executive Officer, Promoter | |
| Hossein T. Ekrami | Director | |
| Eugene R. Scavola | Executive Officer, Promoter | |
| John A. Stalfort | Executive Officer, Director, Promoter | |
| Damian R. deGoa | Executive Officer, Promoter | |
| BKB Growth Investments, T. LLC | Promoter | |
| Paul B. Manning | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Sep 19, 2016 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Dova Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.